Phesi

Phesi provides AI-driven patient-centric data analytics and services that accelerate clinical development across the pharmaceutical and biotech industry. Its flagship Trial Accelerator™ platform leverages the world’s largest contextualized real-time clinical development database to optimize program design, protocol creation, site selection, patient profiling, digital twins/trial arms simulation, and trial execution. The company’s solutions are trusted by leading global pharma companies to improve efficiency in trial design/execution and reduce timelines while maintaining high standards of data integrity. In September 2024 it received Frost & Sullivan's Global Enabling Technology Leadership Award for its impact on the industry.